Next 10 |
home / stock / knbwy / knbwy news
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
2023-12-15 15:10:23 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...
2023-11-21 08:46:55 ET More on Orchard Therapeutics Orchard Therapeutics: A Reassessment Biggest stock movers today: BlackBerry, Clorox, Rivian Automotive and more Kyowa Kirin to buy Orchard Therapeutics for $387M Seeking Alpha’s Quant Rating on Orchar...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Kirin Holdings Co., Ltd. ADR (KNBWY) is expected to report for Q3 2023
2023-10-05 05:24:47 ET More on both companies Orchard Therapeutics: A Reassessment Orchard Therapeutics: Highly Valued Once, Undervalued Today Orchard Therapeutics stock jumps 13% as FDA accepts BLA for OTL-200 For further details see: Kyowa Kirin to buy ...
2023-09-24 23:33:31 ET Summary Kyowa Kirin shares are viewed as a cheap option on the positive outcome for the atopic dermatitis drug being developed with Amgen. The company's recent track record for new drug trial success has been poor, but the partnership with Amgen provides rea...
2023-08-08 07:05:56 ET Kirin Holdings Company, Limited press release ( OTCPK:KNBWY ): 1H GAAP EPS of ¥39.49. Revenue of ¥970.23B (+5.8% Y/Y). For further details see: Kirin Holdings Company, Limited GAAP EPS of ¥39.49, revenue of ¥970.23B
2023-04-25 04:31:23 ET Summary Kirin Holdings is executing positive price hikes, business portfolio management, and a greater commitment to raising profitability. Earnings visibility looks positive, with continued price increases in beverages, steady overseas expansion, and steady...
2023-04-19 05:20:19 ET Summary We are now climbing a wall of worry in the stock market. How “Climbing a Wall of Worry” rallies end. How to invest from now until the end of the wall of worry. The stock market is often said to climb a wall of worry. This ...
News, Short Squeeze, Breakout and More Instantly...
Kirin Holdings Co Ltd ADR Company Name:
KNBWY Stock Symbol:
OTCMKTS Market:
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Kirin Holdings Co., Ltd. ADR (KNBWY) is expected to report for Q3 2023